John W. Simon
Founder at Forge Therapeutics LLC
Network origin in John W. Simon first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA.
32
| Subsidiary | Pharmaceuticals: Major | 32 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to John W. Simon via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| NEUROLOGIX, INC. | Internet Software/Services | President Chief Executive Officer | |
KOS Pharmaceuticals, Inc.
 KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | Pharmaceuticals: Major | General Counsel Chief Executive Officer Corporate Officer/Principal | |
| POZEN INC. | Pharmaceuticals: Major | President Chief Executive Officer Compliance Officer | |
| STANDARD BIOTOOLS INC. | Medical Specialties | Corporate Officer/Principal | |
| CORREVIO PHARMA CORP. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| AUXILIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Administrative Officer Chief Executive Officer Corporate Officer/Principal | |
FoldRx Pharmaceuticals LLC
 FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FoldRx Pharmaceuticals, Inc. provides drug discovery and clinical development services. It develops and discovers products focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding. The company was founded by Jeffery W. Kelly and Susan L. Lindquist in 2003 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
MAP Pharmaceuticals LLC
 MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Medical Specialties | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| VANDA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Sales & Marketing | |
| KALA BIO, INC. | Pharmaceuticals: Major | Director/Board Member Compliance Officer President Corporate Officer/Principal | |
| WAVE LIFE SCIENCES LTD. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| University of Virginia | College/University | Doctorate Degree Doctorate Degree | |
| College of the Holy Cross (Massachusetts) | College/University | Undergraduate Degree Undergraduate Degree | |
Arsenal Capital Management LP
 Arsenal Capital Management LP Investment ManagersFinance Arsenal Capital Management LP (Arsenal Capital) is a private equity subsidiary of Arsenal Capital Group LLC founded in 2000 by Terrence M. Mullen and Jeffrey B. Kovach. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
| SANTHERA PHARMACEUTICALS HOLDING AG | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer | |
| Babson College | College/University | Masters Business Admin Masters Business Admin | |
| Fairfield University | College/University | Undergraduate Degree | |
| University of Arizona | College/University | Undergraduate Degree | |
| University of Vermont | College/University | Undergraduate Degree Doctorate Degree | |
Xenetic Biosciences (UK) Ltd.
 Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chief Operating Officer | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| OPKO HEALTH, INC. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
| Astra Pharmaceuticals, Inc. | Chief Tech/Sci/R&D Officer | ||
| CHROMADEX CORPORATION | Pharmaceuticals: Other | Director/Board Member | |
ProQuest Management LLC (Canada)
 ProQuest Management LLC (Canada) Investment ManagersFinance Founded in 1998, ProQuest Investments Canada is a healthcare venture capital firm located in Montreal. The firm is Canadian investment arm of US-based ProQuest Investments | Investment Managers | Private Equity Investor | |
| SOCIETAL CDMO, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| WINSTON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| SORRENTO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| University of Illinois College of Medicine | College/University | Doctorate Degree | |
Torreya Partners LLC
 Torreya Partners LLC Investment ManagersFinance Torreya Partners LLC engages in provision of financial advisory services. The company was founded by Tim Opler and Mark Simon in 2007 and is headquartered in New York, NY. | Investment Managers | Consultant / Advisor | |
| PHIO PHARMACEUTICALS CORP. | Biotechnology | Director/Board Member | |
Guardum Pharmaceuticals LLC
 Guardum Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Pharmsynthez PJSC, Guardum Pharmaceuticals LLC produces pharmaceutical preparations. The company is based in Miami, FL. Guardum Pharmaceuticals was acquired by Pharmsynthez PJSC on April 18, 2013. | Pharmaceuticals: Major | Chief Executive Officer | |
| CLEMENTIA PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| XENETIC BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
SciVac Ltd.
 SciVac Ltd. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., SciVac Ltd. is an Israeli company that develops and markets biological products for human healthcare. The company is based in Rehovot, Israel. SciVac was acquired by Levon Resources Ltd. on July 09, 2015 for $73.16 million. | Biotechnology | Chief Executive Officer | |
| PULMATRIX, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| OLD API WIND-DOWN LTD. | Pharmaceuticals: Major | President Chief Executive Officer Compliance Officer | |
| VBI VACCINES INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
TPG Sixth Street Partners LLC
 TPG Sixth Street Partners LLC Investment ManagersFinance TPG Sixth Street Partners LLC (TPG Sixth Street Partners) is a private equity and venture capital firm founded in 2009 by Alan Samuel Waxman and Joshua William Easterly. The firm is headquartered in San Francisco, California. | Investment Managers | Consultant / Advisor |
Statistics
International
| United States | 40 |
| Canada | 5 |
| Israel | 3 |
| Singapore | 2 |
| Switzerland | 2 |
Sectoral
| Health Technology | 35 |
| Consumer Services | 8 |
| Finance | 5 |
| Technology Services | 2 |
| Health Services | 2 |
Operational
| Director/Board Member | 110 |
| Corporate Officer/Principal | 58 |
| Chief Tech/Sci/R&D Officer | 49 |
| Independent Dir/Board Member | 32 |
| President | 31 |
Most connected contacts
| Insiders | |
|---|---|
| Mark Corrigan | 29 |
| Timothy James Rink | 23 |
| Curtis Lockshin | 20 |
| Trevor Phillips | 20 |
| Adrian Adams | 19 |
| Andrew Koven | 16 |
| Jim O'Shea | 16 |
| David Hastings | 12 |
| Donna Grogan | 12 |
| Antony Loebel | 11 |
| William McVicar | 11 |
| James M. Roach | 11 |
| Paul D. Rubin | 10 |
| Eric Trachtenberg | 10 |
| Jeremy Goldberg | 9 |
- Stock Market
- Insiders
- John W. Simon
- Company connections
